Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Two Business Units with New Management

Published: Wednesday, November 14, 2012
Last Updated: Wednesday, November 14, 2012
Bookmark and Share
Leadership change at Bosch Packaging Technology.

Uwe Harbauer takes on his new position as Senior Vice President Business Unit Pharma at Bosch Packaging Technology in Crailsheim, Germany, on January 1, 2013. He replaces Wolfgang Szczerba, who retires after 34 years at Bosch. Harbauer himself will be succeeded as Senior Vice President Packaging Services in Beringen, Switzerland, by Walter Häcki (48). Häcki already moved to his new position on November 1, 2012.

Mechanical engineer Szczerba, who will celebrate his 60th birthday in January, started his career as development engineer in the Packaging Technology division back in 1981. In 2000, he became technical plant manager of the Crailsheim site, and since 2002 he has been responsible for Bosch Packaging Technology’s Pharma business unit.

Harbauer with long-term sales and service experience
His successor Uwe Harbauer also graduated in mechanical engineering and started working for Bosch Packaging Technology in 2000. He draws on many years of experience as head of sales of the Pharma business unit, and as senior vice president in charge of customer service. Most recently he held the position of Senior Vice President Business Unit Packaging Services in Beringen, Switzerland.

Walter Häcki takes over Packaging Services business unit
Walter Häcki (48) already took on his new position as Senior Vice President Business Unit Packaging Services on November 1, 2012. Swissborn Häcki graduated as trade merchant and, in 2000, started working for Sigpack Systems, which has been part of Bosch since 2004. He was headof supply chain management in Beringen, and member of the executive management in Budapest, Hungary. From 2008 to 2012, Häcki was responsible for Bosch Packaging Technology’s Chinese locations in Hangzhou (Zhejiang province) and Chengdu (Sichuan province). Chee Kiang Kang has succeeded Häcki in China. Kang worked as site manager in Singapore and has gained experience as a product manager in Germany in preparation for his new functions in China.

Internationally experienced executives
On behalf of the executive management, Friedbert Klefenz, president of Bosch Packaging Technology, thanked Wolfgang Szczerba for his commitment over the past decades. At the same time, he wished Walter Häcki, Uwe Harbauer and Chee Kiang Kang success in their new positions. “These appointments once again underline the long-term orientation of Bosch Packaging Technology. Both business units, as well as the entire division, will profit from long-term and international experience of their new managers,” said Klefenz.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Bosch and Klenzaids Plan Joint Venture in India
Expansion of activities within pharmaceutical sector.
Thursday, December 04, 2014
Bosch Packaging Technology to Build Second Plant in China
Production in Chengdu to begin in early 2012 in leased production hall.
Tuesday, November 08, 2011
Scientific News
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Protein Protects Against Flu in Mice
The engineered molecule doesn’t provoke inflammation and may hail a new class of antivirals.
Crowdfunding the Fight Against Cancer
From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Natural Protein Points to New Inflammation Treatment
Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
Crouching Protein, Hidden Enzyme
A new study led by scientists at The Scripps Research Institute (TSRI) and the University of California (UC), Berkeley shows how a crucial molecular enzyme starts in a tucked-in somersault position and flips out when it encounters the right target.
Utilizing Antibodies from Ebola Survivors
A collaborative team from The University of Texas Medical Branch at Galveston, Vanderbilt University, The Scripps Research Institute and Integral Molecular Inc. have learned that antibodies in the blood of people who have survived a strain of the Ebola virus can kill various types of Ebola.
Engineering Foe into Friend
Bose Grant awardee Jacquin Niles aims to repurpose the malaria parasite for drug delivery.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!